Menu
sharewise sharewise
Log in
Sign up
Log in
Sign up
Microsoft strongly encourages users to switch to a different browser than Internet Explorer as it no longer meets modern web and security standards. Therefore we cannot guarantee that our site fully works in Internet Explorer. You can use Chrome or Firefox instead.
Top Performance

Predictions

sell
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.40
24.10.23
-
24.10.24
-62.14%
28.10.23

Could be worthwhile Investment >10% per year
Global_Player 
24.10.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.23
17.09.23
-
17.09.24
-11.30%
02.10.23

Could be very worthwhile Investment >20% year
quelbe60 
17.09.23 50%
buy
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.00
19.05.23
€2.20
19.05.24
-63.20%
01.10.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
geldnutzer 
19.05.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.85
03.09.23
-
03.09.24
-7.01%
16.09.23

Could be worthwhile Investment >10% per year
bundfuture 
03.09.23 50%
sell
Canopy Growth Corp

Start price
Target price
Perf. (%)
€1.30
14.09.23
-
14.09.24
-1.50%
16.09.23

Probably not worthwhile Investment
Vassago1 
14.09.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.98
21.08.23
-
21.08.24
-1.45%
02.09.23

Could be very worthwhile Investment >20% year
quelbe60 
21.08.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€9.08
07.08.23
-
07.08.24
-1.10%
19.08.23

Risky Investment
Wolf_of_WS 
07.08.23 50%
sell
Canopy Growth Corp

Start price
Target price
Perf. (%)
€1.93
11.03.23
€0.30
11.03.24
-77.19%
08.07.23

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
geldnutzer 
11.03.23 50%
sell
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€4.22
11.03.23
€4.60
11.03.24
18.48%
19.05.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
geldnutzer 
11.03.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€8.87
24.03.23
-
24.03.24
12.58%
18.05.23

Could be very worthwhile Investment >20% year
quelbe60 
24.03.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€5.55
03.01.23
-
03.01.24
78.44%
14.05.23

Could be worthwhile Investment >10% per year
bundfuture 
03.01.23 50%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€25.86
27.10.21
€40.00
31.12.23
-59.32%
08.05.23

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
27.10.21 70%
buy
Fennec Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€7.45
18.10.21
€12.00
31.12.23
-2.68%
08.05.23

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
18.10.21 60%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.49
10.10.21
€5.00
31.12.23
-32.83%
08.05.23

Could be very worthwhile Investment >20% year
IfYouCanDreamItYouCanDoIt 
10.10.21 60%
buy
Aurinia Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€6.46
04.01.23
€12.00
31.12.25
63.49%
05.05.23

Could be very worthwhile Investment >20% year
BiotechBee 
04.01.23 60%
sell
BELLUS Health Inc.

Start price
Target price
Perf. (%)
€13.20
18.04.23
-
18.04.24
-1.52%
27.04.23

Growths slower than the competition
Higher risks for its business
fenjal 
18.04.23 50%
sell
Organigram Holdings Inc.

Start price
Target price
Perf. (%)
€4.23
28.05.22
-
28.05.23
-56.27%
24.04.23

Probably not worthwhile Investment
Lokrim 
28.05.22 20%
buy
Arbutus Biopharma Corp.

Start price
Target price
Perf. (%)
€3.79
20.09.21
-
20.09.25
-26.16%
03.04.23

Could be worthwhile Investment >10% per year
Lutz69 
20.09.21 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€1.77
21.03.23
-
21.03.24
-7.32%
02.04.23

Could be very worthwhile Investment >20% year
thomasw 
21.03.23 50%
sell
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€16.34
12.09.22
-
12.09.23
-93.70%
02.04.23

Could be very worthwhile Investment >20% year
Vassago1 
12.09.22 50%
buy
InMed Pharmaceuticals Inc.

Start price
Target price
Perf. (%)
€1.30
20.03.23
-
20.03.24
6.18%
23.03.23

Could be worthwhile Investment >10% per year
Capable Management
Good culture
Little innovation
me8 
20.03.23 0%
buy
Promis Neurosciences Inc.

Start price
Target price
Perf. (%)
€5.37
21.07.22
€5.30
21.07.23
-21.42%
11.03.23

ROE lower than 10% per year
Probably not worthwhile Investment
Revenue decline/stagnation expected
EBIT decline/stagnation expected
geldnutzer 
21.07.22 50%
buy
Canopy Growth Corp

Start price
Target price
Perf. (%)
€3.63
19.11.22
€2.50
19.11.23
-46.91%
11.03.23

Lower EBIT Margin than peer group
High valuation
Very low/no dividend yield expected
Risky balance sheet
geldnutzer 
19.11.22 50%
buy
Aphria Inc.

Start price
Target price
Perf. (%)
€12.71
01.03.23
€14.00
-
02.03.23

Revenue growth >5% per year expected
EBIT growth >5% per year expected
Standard Investments for future growth
High dividend yield expected
Traumtanz 
01.03.23 50%
buy
Sernova Corp.

Start price
Target price
Perf. (%)
€0.65
05.01.23
€25.00
05.02.23
23.66%
06.02.23

Could be very worthwhile Investment >20% year
nerosflame 
05.01.23 50%